Recombinant human erythropoietin in chemotherapy-associated anemia
β Scribed by Stefano Cascinu; Giuseppina Catalano; Riccardo Cellerino
- Book ID
- 116127819
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 995 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0305-7372
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND AND METHODS. Nine patients with hormone-refractory metastatic prostatic adenocarcinoma and anemia were treated with recombinant human erythropoietin (rHuEpo) at a median dose of 150 U/kg BW 3 times a week subcutaneously. Baseline hemoglobin (Hb) ranged from 70 to 116 g/L, and the stu
## Abstract Chemotherapyβinduced anemia in children with cancer is usually of acute onset. To investigate an alternate treatment to transfusion (Tx), we undertook a phase IβII clinical trial of daily administrations of recombinant erythropoietin (rHuEPO). Patients with a hemoglobin (Hgb) value <75